Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Attomarker’s next-generation Triple Antibody Test for use in the UKThe Attomarker test detects antibodies to three different COVID-19 proteins in seven...
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
Testing for COVID-19 currently relies on detecting virus RNA in a swab sample from the patient’s throat or nose. Laboratory analysis tells you if you have the virus where you were swabbed. It does not tell you if you have the...
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
Attomarker is supporting Professor Andrew Shaw’s research group at the University of Exeter in a series of important experiments to understand patient responses to the covid-19 coronavirus. Attomarker technology will allow...
The Dangers of Superbugs
NESTA, the organisers of the Longitude Prize, have produced a short film about the dangers of growing antibiotic resistance, especially in India. Professor Andrew Shaw, who was invited to the Superbugs Round Table and Exhibition...
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
On the eve of 2020, The London Times published its annual assessment of key figures who they predicted would shape the business world in 2020 - the Ones to Watch “as we enter a new decade that could herald dramatic change”. Along...
The world’s largest medicine galleries open at the Science Museum Saturday 16th November, and Attomarker is there
The entire first floor of the Science Museum has been transformed into ‘Medicine: The Wellcome Galleries’, bringing together 3,000 medical artefacts, artworks, interactive games and immersive experiences in a vast new permanent...
Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford
The annual OBN Life Sciences Awards, now in their 11th year, attracts the great, the good, and the up and coming of the UK life sciences industry, 300 of whom attended last night’s ceremony in Oxford. Celebrating innovation and...
Attomarker the only British diagnostic device on show at the New York AMR summit, being held around the UN General Assembly opening, September 23rd, 2019
The success of the Science Museum’s “Superbugs” exhibition, currently travelling throughout China and India, has now resulted in an invitation to attend an AMR (antimicrobial resistance) summit being held in parallel with...
Attomarker invited to India to help in the fight against antimicrobial resistance
Attomarker is delighted to be invited to India at the opening of “Superbugs. The End of Antibiotics?” exhibition in Delhi on 6th September 2019. The exhibition is being formally opened by India’s Health Minister, Harsh...
